KDIGO and ISPD recommendations rewritten as if-then bedside algorithms. Each page lists its source chapter, last-reviewed date, named reviewer, and known controversies. Click a topic to read the distilled version.
CGA staging, surveillance frequency by risk band, when to refer, SGLT2i in CKD, ACEi/ARB thresholds.
HbA1c targets by stage, SGLT2i + GLP-1 RA + finerenone pillars, hypoglycaemia risk stratification.
Standardised office BP, < 120 mmHg systolic target, lifestyle plus ACEi/ARB foundation.
IgA nephropathy, lupus nephritis, FSGS, membranous nephropathy — induction & maintenance algorithms.
KDIGO staging, fluid responsiveness, when to start RRT, sepsis-AKI, contrast-associated AKI.
Iron-first algorithm, ESA initiation, HIF-PHI positioning, target Hb bands and safety caps.
Pre-transplant workup, contraindications, malignancy and infection clearance, sensitisation testing.
Induction, maintenance immunosuppression, infection prophylaxis, rejection management, recurrence.
Donor evaluation framework, long-term risk projection, follow-up commitments, ethical guardrails.
Peritonitis prevention and treatment, prescription, ultrafiltration management, encapsulating peritoneal sclerosis.
KDOQI fistula-first principles, catheter avoidance, surveillance for stenosis, infection prevention.
PTH, calcium, phosphate targets by stage; selective vitamin D analogues; calcimimetics in dialysis.
Every distilled summary on NephroZayan links back to the full primary guideline. Where evidence has moved since publication, the page lists the relevant trial, the direction of change, and whether the recommendation has been formally updated. Where controversy exists, both positions are stated.